Intrathecal Pharmacology Update: Novel Dosing Strategy for Intrathecal Monotherapy Ziconotide on Efficacy and Sustainability

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1403|18|5|414-420

ISSN： 1094-7159

Source： NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol.18, Iss.5, 2015-07, pp. : 414-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)

By  

PAIN PRACTICE, Vol. 18, Iss. 2, 2018-02 ,pp. : 230-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Rhabdomyolysis in a Patient with Long‐Term Exposure to Intrathecal Ziconotide: A Case Report

By  

PAIN PRACTICE, Vol. 15, Iss. 3, 2015-03 ,pp. : E34-E39

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of combined spinal-epidural technique to compare intrathecal ziconotide and epidural opioids for trialing intrathecal drug delivery

By Gulati Amitabh   Loh Jeffrey   Puttanniah Vinay   Malhotra Vivek  

Pain Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 123-128

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK

By Dewilde S.   Verdian L.   MacLaine G. D. H.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 2007-2019

Informa Healthcare

Access to resources Recommend Favorite

The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature

By  

PAIN MEDICINE, Vol. 16, Iss. 7, 2015-07 ,pp. : 1265-1277

John Wiley & Sons Inc

Access to resources Recommend Favorite